Human BioSystems
Human BioSystems: U.S. Patent Office Grants Human BioSystems Its Third Patent
Corporate-news transmitted by DGAP – a company of EquityStory AG.
The issuer is solely responsible for the content of this announcement.
——————————————————————————
U.S. Patent Office Grants Human BioSystems Its Third Patent: U.S. Patent
#7/029,839, “Methods & Solutions for Storing Donor Organs”
Palo Alto, CA – May 10, 2006 – (OTCBB:HBSC) – Human BioSystems, developer
of preservation platforms for organs and other biomaterials, announced
today that the U.S. Patent Office approved its patent for organ
preservation entitled “Methods and Solutions for Storing Donor Organs” U.S.
patent number 7/029,839. The current shelf-life of human donor organs is
very short — depending upon the organ, they must be transplanted within 3
to 36 hours. While maintaining viability, quality and safety, the Human
BioSystems technology is designed to extend the shelf life of these organs
longer than is now possible.
“We believe that Human BioSystems is the first to fill a current need of
the medical community by providing a method of organ preservation that is
estimated to save millions of dollars each year in anti-rejection drugs
alone as a result having more time to have a better donor/recipient match.
With more than 173,000 patients on transplant waiting lists, this new organ
preservation technology can save untold lives. Longer shelf life of organs
should benefit patients, surgeons, hospitals and insurance companies,”
explained Luis Toledo, MD, Chief Medical Officer of Human BioSystems.
Human BioSystems has two earlier approved patents: “Method & Apparatus for
Preserving Biological Materials,” US patent no. 6,413,713, and “Methods and
Apparatuses for Preserving Platelets,” U.S. Patent No. 6,828,090.
“With the granting of this third patent, we are confident that we will have
more possibilities to continue to secure strategic alliances of partners as
we progress through our testing phases,” stated David Winter, MD, President
of Human BioSystems.
HBS is headquartered in Palo Alto, California with research facilities in
Michigan.
Human BioSystems (OTC Bulletin Board: HBSC – News)
Contact:
Human BioSystems Investor Relations
Harry Masuda Yes International
CEO Rich Kaiser
(650) 323-0943 (800) 631-8127
hmasuda@humanbiosystems.com rich@yesinternational.com
(c)DGAP 12.05.2006
—————————————————————————
Language: English
Issuer: Human BioSystems
1127 Harker Avenue
CA 94301, Palo Alto Vereinigte Staaten von Amerika
Phone: 001-650-323-0943
Fax: 001-650-327-8658
email: info@humanbiosystems.com
WWW: www.humanbiosystems.com
ISIN: US44485X1090
WKN: 157049
indices:
End of News DGAP News-Service
—————————————————————————
Latest News
Latest Reports
Upcoming Events
No Events found